Static C Immunoglobulin is suitable for people with severe infections, neonatal sepsis and primary thrombocytopenic purpura. Static C Immunoglobulin is an immune-enhancing drug that recognizes and binds antigens, activates complement and promotes macrophage response. 1. Critical infections: continuous use can effectively enhance the function of the immune system, thereby stimulating the immune cells to spontaneously fight against foreign infectious bacteria, fungi or viruses, and thus produce corresponding antibodies. 2. Neonatal sepsis: the specific dosage of the drug needs to be selected according to the weight and the severity of the disease. After use, it can effectively increase the level of antibodies in children’s bodies, thus improving the immune function and alleviating the symptoms of infection or immune damage caused by sepsis. 3. Primary thrombocytopenic purpura: the dosage of this drug should be chosen according to the body weight, and can be infused continuously to observe the platelet count and the stability of the condition through the intervals. Adverse reactions such as transient headache, panic and nausea may occur with the use of static C immunoglobulin. It is contraindicated in persons who are hypersensitive to human immunoglobulin or have a history of other severe allergies, and in persons with selective IgA deficiency who have anti-IgA antibodies. Note that this product can only be injected intravenously, once the bottle is opened it should be used up at once, and the unused portion should be discarded. The use of Static C Immunoglobulin should be under the professional guidance of a doctor to avoid adverse effects.